Recently, NQO1 overexpression was reported to be a potent independent biomarker for prognostic evaluation of HCC (13) and enhanced apoptosis inhibition of liver cancer cells via the SIRT6/AKT/XIAP signaling pathway (14, 15). This evidence concerns the gene NQO1 and hepatocellular carcinoma.